Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty

Osteoarthritis (OA), a disease affecting different patient phenotypes, appears as an optimal candidate for personalized healthcare. The aim of the discussions of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group was to explore the value o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Aging
Main Authors: Arden, Nigel, Richette, Pascal, Cooper, Cyrus, Bruyère, Olivier, Abadie, Eric, Branco, Jaime, Brandi, Maria Luisa, Berenbaum, Francis, Clerc, Cécile, Dennison, Elaine, Devogelaer, Jean-Pierre, Hochberg, Marc, D’Hooghe, Pieter, Herrero-Beaumont, Gabriel, Kanis, John A., Laslop, Andrea, Leblanc, Véronique, Maggi, Stefania, Mautone, Giuseppe, Pelletier, Jean-Pierre, Petit-Dop, Florence, Reiter-Niesert, Susanne, Rizzoli, René, Rovati, Lucio, Tajana Messi, Eleonora, Tsouderos, Yannis, Martel-Pelletier, Johanne, Reginster, Jean-Yves
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2015
Assuntos:
Current Opinion
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4516900/
https://ncbi.nlm.nih.gov/pubmed/26085027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-015-0276-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados